NFKB1 and cancer: In cancer, DUB family members affect multiple tumor‐related signaling pathways, such as NF‐κB, PI3K/Akt/mTOR, Wnt/β‐catenin, Hippo, and TGF‐β, by precisely regulating key molecules like transcription factors and signaling proteins.